Stock Market Watch

Eight NASDAQ Stocks under Four Bucks to Watch for Friday

by ·


Complete Genomics, Inc. (NASDAQ:GNOM) traded as high as $2.10 during Thursday’s trading session and last traded at the high for a gain of 17.32% from Wednesday’s close… GNOM shares have traded as high as $16.76 over the past 52 weeks, which is 87.47% off that high at last traded stock price. Get my next ALERT 100% FREE

Complete Genomics Inc is a life sciences company that has developed and commercialized an innovative DNA sequencing platform that provides preferred solution for complete human genome sequencing and analysis.

JA Solar Holdings Co., Ltd. ADR (NASDAQ:JASO) traded as high as $1.16 during Thursday’s trading session and last traded at $1.09 for a gain of 17.2% from Wednesday’s close… JASO shares have traded as high as $5.74 over the past 52 weeks, which is 81.01% off that high at last traded stock price.


JA Solar Holdings one of the world’s largest manufacturers of high-performance solar cells and solar power products, today announced that it has joined Intertek’s “Satellite Program.” A strategic cooperation MOU was also signed between Intertek and JA Solar to strengthen cooperation in the fields of quality, safety and ecology.

Genetic Technologies Limited (NASDAQ:GENE) traded as high as $3.84 during Thursday’s trading session and last traded at $3.56 for a gain of 13.02% from Wednesday’s close… GENE shares have traded as high as $10.75 over the past 52 weeks, which is 66.88% off that high at last traded stock price.

Genetic Technologies Limited is engaged in a diagnostic product business. The Company translates genetic tests into products and services. The Company’s cancer diagnostics business focused on building a sustainable stable of products and services. The Company operates in three divisions: genetic testing, including cancer diagnostics; licensing, and research.

Biosante Pharmaceuticals Inc (NASDAQ:BPAX) traded as high as $2.37 during Thursday’s trading session and last traded at the high for a gain of 11.79% from Wednesday’s close… BPAX shares have traded as high as $24.13 over the past 52 weeks, which is 90.18% off that high at last traded stock price. Get my next ALERT 100% FREE

Biosante Pharmaceuticals, Inc. is a specialty pharmaceutical company, focused on developing products for female sexual health, menopause, contraception and male hypogonadism.

Delcath Systems, Inc. (NASDAQ:DCTH) traded as high as $1.57 during Thursday’s trading session and last traded at the high for a gain of 11.35% from Wednesday’s close… DCTH shares have traded as high as $6.64 over the past 52 weeks, which is 76.36% off that high at last traded stock price.

Delcath Systems, Inc. is a development stage company focusing on the development of the Delcath PHP System, an innovative drug delivery system designed to treat cancers of the liver.

Dot Hill Systems Corp. (NASDAQ:HILL) traded as high as $1.28 during Thursday’s trading session and last traded at $1.27 for a gain of 9.48% from Wednesday’s close… HILL shares have traded as high as $3.18 over the past 52 weeks, which is 60.06% off that high at last traded stock price.

Dot Hill Systems Corp. designs, manufactures and markets a range of software and hardware storage systems for the entry and midrange storage markets. The Company operates in two segments: storage systems and standalone storage software.

Lattice Semiconductor (NASDAQ:LSCC) traded as high as $4.30 during Thursday’s trading session and last traded at $3.85 for a loss of 14.25% from Wednesday’s close… LSCC shares have traded as high as $7.17 over the past 52 weeks, which is 46.34% off that high at last traded stock price. Get my next ALERT 100% FREE

Lattice Semiconductor Corporation designs, develops and markets programmable logic products and related software. The Company participates in both the field programmable gate arrays (FPGA) and programmable logic devices (PLD) markets.

Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA) traded as high as $3.08 during Thursday’s trading session and last traded at $2.72 for a loss of 12.26% from Wednesday’s close… ALXA shares have traded as high as $19.10 over the past 52 weeks, which is 85.76% off that high at last traded stock price.

Alexza Pharmaceuticals, Inc. is a pharmaceutical development company focused on the research, development, and commercialization of novel proprietary products for the acute treatment of central nervous system conditions.

More Posts by this author

Post Written By: Oliver Crowne
Oliver Crowne is the main editor for http://www.StockPreacher.com

Ed Liston

Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications. He is widely quoted in various financial publications on the Internet. When Ed is not writing about stocks, investing in stocks, talking about stocks, or otherwise doing something stock related, he likes to go sailing and fishing.

You may also like...